Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte Congratulates AstraZeneca’s Jonathan Wingfield, Winner of the 2015 SLAS Innovation Award

Winning Presentation about Acoustic Liquid Handling Now Available Online for Public View

April 29, 2015

Sunnyvale, CA

SUNNYVALE, CALIF – April 29, 2015 – Labcyte Inc., a company revolutionizing life science research with its patented acoustic liquid handling technology, congratulates Dr. Jonathan Wingfield, Associate Principal Scientist, Discovery Sciences, Screening Sciences and Sample Management at AstraZeneca for receiving the Innovation Award and a $10,000 prize at SLAS2015, the annual conference and exhibition of the Society for Laboratory Automation and Screening (SLAS), held Feb. 7-11 in Washington D.C.  His presentation, now available for viewing on the SLAS website (http://www.slas.org/slas2015-webinar/), is titled “Novel Acoustic Loading of a Mass Spectrometer — Towards Next Generation High Throughput MS Screening.” 

Dr. Wingfield presented preliminary results for the application of Labcyte’s acoustic liquid handling to directly load a mass spectrometer.  The SLAS Innovation Award is presented to the “podium presentation at the SLAS Annual Conference that proves to be exceedingly innovative and contributes to the exploration of technologies in the laboratory, exceeds a benchmark or milestone in screening or the lead discovery process, or demonstrates an advanced and integrated use of mature technologies.”

The goal of this work, performed in collaboration between AstraZeneca and Labcyte, is to expand the utility of mass spectrometry for high-throughput, low-cost, label-free analysis.  This capability would expand the use of mass spectrometry-based analysis throughout the entire drug discovery and development process. Dr. Wingfield presented data from a prototype instrument developed by Labcyte, capable of injecting at a rate of three samples per second, or nearly 30 times faster than the commercially available techniques used today. 

This data shows promise for the acoustic liquid handling technique in the analysis of small molecules, simple proteins and more complex large proteins. “Direct infusion mass spectrometry offers a significant step change in throughput,” said Dr. Wingfield. “The ability to load 10,000 samples per hour is now a realistic objective that would enable HTS to exploit the full potential of mass spectrometry. Acoustic technology means contactless sample delivery, and therefore low carryover, ultra-low sampling volumes and very high loading rates.”

The next step in the collaboration will focus on further characterizing the breadth of capabilities for this technology with the ultimate goal of launching a commercial product available to all researchers.  “The SLAS Innovation Award is great recognition of the outstanding work that has been done by Dr. Wingfield and his team and serves as a testament to the accomplishments that can be achieved when innovative companies and thought leaders work together,” said Mark Fischer-Colbrie, Labcyte President and CEO. “The award also indicates the tremendous value a commercial product would bring to organizations looking to improve assays, sample measurement and experimental results.” 

About Labcyte Inc.
Labcyte, a global biotechnology tools company headquartered in Sunnyvale, California, is revolutionizing liquid handling. Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, as well as by biotechnology companies, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics, personalized medicine, and imaging mass spectrometry. Labcyte has 55 U.S. patents and others internationally. For more information, visit www.labcyte.com.
 




MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP